JF
Jump Financial Portfolio holdings
AUM
$8.14B
1-Year Return
18.67%
This Quarter Return
+0.68%
1 Year Return
+18.67%
3 Year Return
+54.31%
5 Year Return
+107.56%
10 Year Return
–
AUM
$4.97B
AUM Growth
+$1.3B
(+35%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
24.34%
Top 10 Holdings %
Top 10 Hldgs %
20.66%
Holding
2,385
New
513
Increased
636
Reduced
565
Closed
646
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$201M |
| 2 |
NVIDIA
NVDA
|
+$57.4M |
| 3 |
Broadcom
AVGO
|
+$44M |
| 4 |
Apple
AAPL
|
+$36.8M |
| 5 |
Amazon
AMZN
|
+$31M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$121M |
| 2 |
ProShares UltraPro Short QQQ
SQQQ
|
+$32.1M |
| 3 |
UnitedHealth
UNH
|
+$16.7M |
| 4 |
Biogen
BIIB
|
+$13M |
| 5 |
Zoetis
ZTS
|
+$12.8M |
Sector Composition
| 1 | Technology | 20.92% |
| 2 | Consumer Discretionary | 10.34% |
| 3 | Healthcare | 10.28% |
| 4 | Industrials | 9.9% |
| 5 | Financials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Aclaris Therapeutics
ACRS
$213M
| $24.8K | ﹤0.01% |
+22,524
| New | +$24.8K |
|
1677
Karyopharm Therapeutics
KPTI
$57.6M
| $23.3K | ﹤0.01% |
+1,787
| New | +$23.3K |
|
1678
Butterfly Network
BFLY
$390M
| $22.7K | ﹤0.01% |
+27,011
| New | +$22.7K |
|
|
QVCGA
1679
QVC Group, Inc. Series A Common Stock
QVCGA
$87.4M
| $22.1K | ﹤0.01% |
700
-7,939
| -92% | -$250K |
|
1680
Assertio
ASRT
$77.5M
| $21.9K | ﹤0.01% |
+17,659
| New | +$21.9K |
|
1681
Babcock & Wilcox
BW
$250M
| $21.6K | ﹤0.01% |
+14,903
| New | +$21.6K |
|
1682
Luminar Technologies
LAZR
$122M
| $21.3K | ﹤0.01% |
+953
| New | +$21.3K |
|
1683
Lumen
LUMN
$6.25B
| $21K | ﹤0.01% |
+19,097
| New | +$21K |
|
|
ME
1684
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $20.7K | ﹤0.01% |
+2,648
| New | +$20.7K |
|
1685
PMV Pharmaceuticals
PMVP
$65.2M
| $19.2K | ﹤0.01% |
+11,873
| New | +$19.2K |
|
1686
Protalix BioTherapeutics
PLX
$139M
| $16.6K | ﹤0.01% |
+14,224
| New | +$16.6K |
|
1687
Citius Pharmaceuticals
CTXR
$20.4M
| $16.6K | ﹤0.01% |
+1,137
| New | +$16.6K |
|
|
MRNS
1688
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $15.6K | ﹤0.01% |
+13,334
| New | +$15.6K |
|
|
MAGN
1689
Magnera Corporation
MAGN
$414M
| $15.5K | ﹤0.01% |
+856
| New | +$15.5K |
|
1690
Microvast
MVST
$916M
| $15.5K | ﹤0.01% |
+33,891
| New | +$15.5K |
|
1691
Origin Materials
ORGN
$81.4M
| $15.1K | ﹤0.01% |
+16,713
| New | +$15.1K |
|
1692
Vuzix
VUZI
$183M
| $13.9K | ﹤0.01% |
+10,288
| New | +$13.9K |
|
1693
Kezar Life Sciences
KZR
$29.1M
| $13.6K | ﹤0.01% |
+2,263
| New | +$13.6K |
|
1694
American Well
AMWL
$109M
| $13.3K | ﹤0.01% |
+2,049
| New | +$13.3K |
|
|
OPTN
1695
DELISTED
OptiNose
OPTN
| $12.9K | ﹤0.01% |
+830
| New | +$12.9K |
|
1696
FibroGen
FGEN
$50.3M
| $12.9K | ﹤0.01% |
+580
| New | +$12.9K |
|
|
CTEV
1697
Claritev Corporation
CTEV
$1.02B
| $12.5K | ﹤0.01% |
+804
| New | +$12.5K |
|
|
ALLK
1698
DELISTED
Allakos
ALLK
| $11.5K | ﹤0.01% |
+11,463
| New | +$11.5K |
|
|
VTNR
1699
DELISTED
Vertex Energy, Inc
VTNR
| $11.4K | ﹤0.01% |
12,096
-899
| -7% | -$849 |
|
1700
Vor Biopharma
VOR
$229M
| $11.3K | ﹤0.01% |
+11,328
| New | +$11.3K |
|